According to data from Virginia Commonwealth University and the Virginia Department of Health.
Key Takeaways
- Approximately 8.5% of adults in Virginia, or nearly 1 in 12, experienced a substance use disorder in the past year.8.5%[3]
- A significant treatment gap exists, with nearly 60% of Virginians diagnosed with SUD not receiving appropriate care.~60%[3]
- Overdose deaths continue to rise, with a 15% increase reported from 2022 to 2023, highlighting a worsening public health crisis.15%[2]
- Young adults aged 18-25 face the highest risk, with a past-year SUD prevalence rate of 12.3%.12.3%[7]
- Rural areas of Virginia experience a disproportionately high SUD prevalence rate of 12%, compared to 7% in urban centers.12% vs 7%[2]
- Virginia's overall mental health ranking dropped significantly from 12th to 22nd nationally between 2024 and 2025.↓10 spots[8]
- Investing in evidence-based opioid care could yield substantial economic benefits, with potential savings of up to $5.2 billion for the state.$5.2B[6]
Prevalence of Substance Use in Virginia
Substance Use Disorder (SUD) represents a significant public health challenge in Virginia, affecting communities across the Commonwealth. Recent data indicates that approximately 8.5% of adults aged 18 and older have experienced SUD in the past year, a figure that translates to nearly one in twelve individuals[3]. This rate is slightly higher than the national average of 7.9%[3]. The issue is often compounded by co-occurring mental health conditions, with an estimated 22.5% of Virginia adults experiencing any mental illness[9]. Understanding the scope of substance use is the first step toward addressing its impact on individuals, families, and the healthcare system.
Data from 2021 shows that tobacco use remains a prevalent issue in the state.
A 2020 survey highlights marijuana as one of the most commonly used substances.
Between 2014-2017, Virginia's rate of alcohol addiction was nearly identical to the national average.
Demographic and Geographic Disparities
Substance Use Disorder does not affect all Virginians equally. Significant disparities exist across different age groups and geographic locations. Research indicates that early onset of substance use is a strong predictor of developing SUD later in life[1], making young people a particularly vulnerable population. Furthermore, there is a disproportionate impact on low-income communities and minority populations[1], as well as a notable divide between rural and urban areas of the state. These disparities underscore the need for targeted interventions and equitable access to resources.
The Treatment Gap: Barriers to Accessing Care
Despite the clear need, a large portion of Virginians with SUD do not receive care. Estimates suggest that only one-tenth of individuals with an SUD receive any form of treatment[4]. This gap is driven by multiple factors, including pervasive stigma, which causes many to fear discrimination or legal consequences[2]. Systemic issues like historical underinvestment in behavioral health also contribute[3]. While Medicaid expansion has improved access for many, bureaucratic hurdles can still hinder care delivery[11], and many with private insurance find their plans do not cover necessary services[8].
Access to Care Metrics
Virginia's statewide provider density exceeds the national average, though distribution is uneven.
Americashealthrankings (2022)Rural areas face a significant shortage of accessible treatment options compared to the rest of the state.
Vdh (2023)Medicaid is a critical source of funding for substance use treatment in the Commonwealth.
Substance Abuse and Mental Health Services Administration (2022)The Provider Landscape
While Virginia's overall density of SUD treatment facilities is higher than the national average, this top-level number masks significant local disparities. Many parts of the state, particularly rural communities, are designated as Health Professional Shortage Areas (HPSAs)[13]. This limited provider density leads to prolonged wait times, challenges related to travel for appointments, and ultimately, lower rates of treatment engagement for residents in these underserved areas[8]. Closing these gaps is essential to ensuring all Virginians have a fair opportunity for recovery.
Overdose Trends and Health Outcomes
The consequences of widespread SUD and treatment gaps are severe, most notably reflected in the state's overdose crisis. Virginia has seen a troubling increase in overdose incidents and deaths in recent years. Between 2019 and 2020 alone, emergency room visits for opioid-related complications surged by 33% to nearly 10,000[1]. This trend of increasing severity highlights the urgent need for expanded harm reduction, prevention, and treatment services across the state.
The Human Cost of the SUD Crisis
The mortality rate from drug overdoses continues to climb, indicating a worsening crisis.
In 2020, the daily death toll from opioids underscored the severity of the epidemic.
Virginia's suicide rate exceeds the national average of 14.0, a statistic often linked to untreated mental health and substance use disorders.
Treatment Outcomes and Interventions
Despite the challenges, effective treatments and interventions are making a difference. Harm reduction centers play a vital role in saving lives on the front lines of the overdose crisis. When individuals are able to access and remain in treatment, positive outcomes are achievable. However, Virginia's overall ranking for youth mental health care remains low at 32nd nationally, indicating a critical need for more investment in services for young people[8]. Strengthening these programs is key to improving long-term health outcomes for Virginians with SUD.
Impact of Treatment and Harm Reduction
These centers provide life-saving interventions and are a critical component of the public health response.
Vdh (2024)This finding from NIDA highlights that recovery is possible with access to effective care.
Hsrd (2023)Economic and Societal Impact
The effects of untreated substance use disorders extend beyond health outcomes, imposing a substantial economic burden on the state. These costs are associated with increased healthcare expenditures, lost productivity, and greater demand on the criminal justice and social service systems[14]. However, investing in evidence-based treatment is not only a public health imperative but also an economic one, with the potential to generate significant savings for the Commonwealth.
Frequently Asked Questions
Sources & References
All statistics and claims on this page are supported by peer-reviewed research and official government data sources.
